Structural biology of HIV

Journal of Molecular Biology

Volumn 285, Issue 1, 1999, Pages 1-32

  Turner, Brian G ^a   Summers, Michael F ^a  

^a UNIVERSITY OF MARYLAND BALTIMORE COUNTY   (United States)

Author keywords

Acquired immunodeficiency syndrome (AIDS); Human immunodeficiency virus (HIV); Nuclear magnetic resonance; Protein structure; X ray crystallography

Indexed keywords

CAPSID PROTEIN; ENVELOPE PROTEIN; ENZYME; INTEGRASE; NUCLEOCAPSID PROTEIN; PROTEINASE; RNA DIRECTED DNA POLYMERASE; STRUCTURAL PROTEIN; TRANSACTIVATOR PROTEIN; VIRUS PROTEIN;

ENZYME STRUCTURE; HUMAN IMMUNODEFICIENCY VIRUS; LIFE CYCLE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN STRUCTURE; REVIEW; VIRION; VIRUS GENOME; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS; MIRIDAE; RNA VIRUSES;

EID: 0033534386     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmbi.1998.2354     Document Type: Article

References (321)

1. Aboul-ela F., Karn J., Varani G. The structure of the human immunodeficiency virus type-1 TAR RNA reveals prinicples of RNA recognition by Tat protein. J. Mol. Biol. 253:1995;313-332.
2. Adman E., Watenpaugh E. D., Jensen L. H. NH - S hydrogen bonds in Peptococcus aerogenes ferredoxin, Clostridium pasteurianum rubredoxin, and Chromatium high potential iron protein. Proc. Natl Acad. Sci. USA. 72:1975;4854-4858.
3. Aldovini A., Young R. A. Mutations of RNA and protein sequences involved in human immunodeficiency virus type 1 packaging result in production of noninfectious virus. J. Virol. 64:1990;1920-1926.
4. Argos P. A possible homology between imunodeficiency virus p24 core protein and picornaviral VP2 coat protein: prediction of HIV p24 antigenic sites. EMBO J. 8:1989;779-785.
5. Arnold E., Jacobo-Molina A., Nanni R. G., Williams R. L., Lu X., Ding J., Clark A. D., Zhang A., Ferris A. L., Clark P., Hizi A., Hughes S. H. Structure of HIV-1 reverse transcriptase/DNA complex at 7 Å resolution showing active site locations. Nature. 357:1992;85-89.
6. Arold S., Franken P., Strub M.-P., Hoh F., Benichou S., Benarous R., Dumas C. The crystal structure of HIV-1 Nef protein bound to the Fyn kinase SH3 domain suggests a role for this complex in altered T cell receptor signaling. Structure. 5:1997;1361-1372.
7. Aronoff R., Hajjar A. M., Linial M. L. Avian retroviral RNA encapsidation: reexamination of functional 5′ RNA sequences and the role of nucleocapsid Cys-His motifs. J. Virol. 67:1993;178-188.
8. Arthur L. O., Bess J. W. Jr, Sowder R. C. I., Benveniste R. E., Mann D. L., Chermann J.-C., Henderson L. E. Cellular proteins bound to immunodeficiency virus: implications for pathogenesis and vaccines. Science. 258:1992;1935-1938.
9. Arts E. J., Wainberg M. A. Human immunodeficiency virus type 1 reverse transcriptase and early events in reverse transcription. Advan. Virus Res. 46:1996;97-163.
10. Barat C., Schatz O., Le Grice S., Darlix J.-L. Analysis of the interactions of HIV1 replication primer tRNA-Lys,3 with nucleocapsid protein and reverse transcriptase. J. Mol. Biol. 231:1993;185-190.
11. Barklis E., McDermott J., Wilkens S., Schabtach E., Schmid M. F., Fuller S., Karanjia S., Love Z., Jones R., Rui Y., Zhao X., Thompson D. Structural analysis of membrane-bound retrovirus capsid proteins. EMBO J. 16:1997;1199-1213.
12. Barklis E., McDermott J., Wilkens S., Fuller S., Thompson D. Organization of HIV-1 capsid proteins on a lipid monolayer. J. Biol. Chem. 273:1998;7177-7180.
13. Barré-Sinoussi F., Chermann J. C., Rey F., Nugeyre M. T., Chamaret S., Gruest J., Dauguet C., Axler-Blin C., Vézinet-Brun F., Rouzioux C., Rozenbaum W., Montagnier L. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science. 220:1983;868-871.
14. 13C-heteronuclear NMR. J. Biomol. NMR. 6:1995;375-389.
15. Battiste J. L., Mao H., Rao N. S., Tan R., Muhandiram D. R., Kay L. E., Frankel A. D., Williamson J. R. α-Helix major groove recognition in an HIV-1 Rev peptide-RRE RNA complex. Science. 273:1996;1547-1551.
16. Bayer P., Kraft M., Ejchart A., Westendorp M., Frank R., Rosch P. Structural studies of HIV-1 Tat protein. J. Mol. Biol. 247:1995;529-535.
17. 1H-NMR spectra and structural characterization in solution of the HIV-1 transframe protein p6*. Eur. J. Biochem. 237:1996;383-392.
18. Bennett R. P., Nelle T. D., Wills J. W. Functional chimeras of the Rous sarcoma virus and human immunodeficiency virus gag proteins. J. Virol. 67:1993;6487-6498.
19. Berg J. M. Potential metal-binding domains in nucleic acid binding proteins. Science. 232:1986;485-487.
20. Berkowitz R. D., Ohagen A., Hoglund S., Goff S. P. Retroviral nucleocapsid domains mediate the specific recognition of genomic viral RNAs by chimeric Gag polyproteins during RNA packaging in vivo. J. Virol. 69:1995;6445-6456.
21. Binley J. M., Wyatt R., Desjardins E., Kwony P. D., Hendrickson W., Moore J. P., Sodroski J. Analysis of the interaction of antibodies with a conserved, enzymatically deglycosylated core of the HIV-1 gp120 envelope glycoprotein. AIDS Res. Hum. Retrovir. 14:1998;191-198.
22. Blake P. R., Summers M. F. Probing the unusually similar metal coordination sites of retroviral zinc fingers and iron-sulfur proteins by nuclear magnetic resonance. Advan. Biophys. Chem. 4:1994;1-30.
23. Bogerd H. P., Fridell R. A., Madore S., Cullen B. R. Identification of a novel cellular cofactor for the Rev/Rex class of retroviral regulatory proteins. Cell. 82:1995;485-494.
24. Bolen J. B. Nonreceptor tyrosine protein kinases. Oncogene. 8:1993;2025-2031.
25. Bowerman B., Brown P. O., Bishop J. M., Varmus H. E. A nucleoprotein complex mediates the integration of retroviral DNA. Genes Dev. 3:1989;469-478.
26. Braaten D., Franke E. K., Luban J. Cyclophilin A is required for an early step in the life cycle of human immunodeficiency virus type-1 before the initiation of reverse transcription. J. Gen. Virol. 1996;3551-3560.
27. Brodsky A. S., Williamson J. R. Solution structure of the HIV-2 TAR-arnininamide complex. J. Mol. Biol. 267:1997;624-639.
28. Brodsky A. S., Erlacher H. A., Williamson J. R. NMR evidence for a base triple in the HIV-2 TAR C-G*C+ mutant-argininamide complex. Nucl. Acids Res. 26:1998;1991-1995.
29. Brown P. O. Integration. Coffin J. M., Hughes S. H., Varmus H. E. Retroviruses. 1997;161-203 Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
30. Bryant M., Ratner L. Myristoylation-dependent replication and assembly of human immunodeficiency virus 1. Proc. Natl Acad. Sci. USA. 87:1990;523-527.
31. Bukrinsky M. I., Haggerty S., Dempsey M. P., Sharova N., Adzhubei A., Spitz L., Lewis P., Goldfarb D., Emerman M., Stevenson M. A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells. Nature. 365:1993;666-669.
32. Caffrey M., Cai M., Kaufman J., Stahl S. J., Wingfield P. T., Gronenborn A. M., Clore G. M. Determination of the secondary structure and global topology of the 44 kDa ectodomain of gp41 of the simian immunodeficiency virus by multidimensional nuclear magnetic resonance spectroscopy. J. Mol. Biol. 271:1997;819-826.
33. Caffrey M., Cai M., Kaufman J., Stahl S. J., Wingfield P. T., Covell D. G., Gronenborn A. M., Clore G. M. Three-dimensional solution structure of the 44 kDa ectodomain of SIV gp41. EMBO J. 17:1998;4572-4584.
34. Cai M., Zheng R., Caffrey M., Craigie R., Clore G. M., Gronenborn A. M. Solution structure of the N-terminal zinc binding domain of HIV-1 integrase. Nature Struct. Biol. 4:1997;567-577.
35. Calnan B. J., Tidor B., Biancalana S., Hudson D., Frankel A. D. Arginine-mediated RNA recognition: the arginine fork. Science. 252:1991;1167-1171.
36. Camaur D., Trono D. Characterization of human immunodeficiency virus type 1 Vif particle incorporation. J. Virol. 70:1996;6106-6111.
37. Carr C. M., Kim P. S. A spring-loaded mechanism for the conformational change of influenza hemagglutinin. Cell. 73:1993;823-832.
38. Chan D. C., Fass D., Berger J. M., Kim P. S. Core structure of gp41 from the HIV envelope glycoprotein. Cell. 89:1997;263-273.
39. Chance M. R., Sagi I., Wirt M. D., Frisbie S. M., Scheuring E., Chen E., Bess J. W. Jr, Henderson L. E., Arthur L. O., South T. L., Perez-Alvarado G., Summers M. F. Extended x-ray absorption fine structure studies of a retrovirus: equine infectious anemia virus cysteine arrays are coordinated to zinc. Proc. Natl Acad. Sci. USA. 89:1992;10041-10045.
40. Chapham P. R., Weiss R. A. Spoilt choice of co-receptors. Nature. 388:1997;230-231.
41. Chazal N., Carriëre C., Gay B., Boulanger P. Phenotypic characterization of insertion mutants of the human immunodeficiency virus type 1 gag precursor expressed in recombinant baculovirus-infected cells. J. Virol. 68:1994;111-122.
42. Checroune F., Yao X.-J., Gottlinger H., Bergeron D., Cohen E. A. Incorporation of Vpr into human immunodeficiency virus type 1: role of conserved regions within the P6 domain of Pr55gag. J. Acquired Immune Defic. Syndr. 10:1995;1-7.
43. Christensen A. M., Massiah M. A., Turner B. G., Sundquist W. I., Summers M. F. Three-dimensional structure of the HTLV-II matrix protein and comparative analysis of matrix proteins from the different classes of pathogenic human retroviruses. J. Mol. Biol. 264:1996;1117-1131.
44. Chun T.-W., Stuyver L., Mizell S. B., Ehler L. A., Mican J. A. M., Baseler M., Lloyd A. L., Nowak M. A., Fauci A. S. Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. Proc. Natl Acad. Sci. USA. 94:1997;13193-13197.
45. Clever J. L., Parslow T. G. Mutant human immunodeficiency virus type 1 genomes with defects in RNA dimerization or encapsidation. J. Virol. 71:1997;3407-3414.
46. Clever J., Sassetti C., Parslow T. G. RNA secondary structure and binding sites for gag gene products in the 5′ packaging signal of human immunodeficiency virus type 1. J. Virol. 69:1995;2101-2109.
47. Coates A. R. M., Cookson J., Barton G. J., Zvelebil M. J., Sternberg M. J. E. AIDS vaccine predictions. Nature. 326:1987;549-550.
48. Coffin J. M. HIV population dynamics in vivo: implications for genetic variation, pathogenesis and therapy. Science. 267:1995;483-489.
49. Cordonnier A., Montagnier L., Emerman M. Single amino acid changes in HIV envelope affect viral tropism and receptor binding. Nature. 340:1989;571-574.
50. Courcoul M., Patience C., Rey F., Blanc D., Harmache A., Sire J., Vigne R., Spire B. Peripheral blood mononuclear cells produce normal amounts of defective vif- human immunodeficiency virus type 1 particles which are restricted for the preretrotranscriptional steps. J. Virol. 69:1995;9358-9365.
51. Crise B., Buonocore L., Rose J. K. CD4 is retained in the endoplasmic reticulum by the human immunodeficiency virus type 1 glycoprotein precursor. J. Virol. 64:1990;5585-5593.
52. Daly T. J., Cook K. S., Gran G. S., Maione T. E., Rusche J. R. Specific binding of HIV-1 recombinant Rev protein to the Rev-response element in vitro. Nature. 342:1989;816-819.
53. Daniel M. D., Kirchoff F., Czajak S. C., Sehgal P. K., Derosiers R. C. Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene. Science. 258:1992;1938-1941.
54. Dannull J., Surovoy A., Jung G., Moelling K. Specific binding of HIV-1 nucleocapsid protein to PSI RNA in vitro requires N-terminal zinc finger and flanking basic amino acid residues. EMBO J. 13:1994;1525-1533.
55. Davies J. F. I., Hostomska Z., Hostomsky Z., Jordon S., Matthews D. A. Crystal structure of the ribonuclease H domain of HIV-1 reverse transcriptase. Science. 252:1991;88-95.
56. Deacon N. J., Tsykin A., Solomon A., Smith K., Ludford-Menting M., Hooker D. J., McPhee D. A., Greenway A. L., Ellett A., Chatfield C., Lawson V. A., Crowe S., Maerz A., Sonza S., Learmont J., Sullivan J. S., Cunningham A., Dwyer D., Dowton D., Mills J. Genomic structure of an attenuated quasi species of HIV-1 from blood transfusion donor and recipients. Science. 270:1995;988-991.
57. Debouck C., Gorniak J. G., Strickler J. E., Meek T. D., Metcalf B. W., Rosenberg M. Human immunodeficiency virus protease expressed in Escherichia coli exhibits autoprocessing and specific maturation of the gag precursor. Proc. Natl Acad. Sci. USA. 84:1987;8903-8906.
58. De Rocquigny H., Gabus C., Vincent A., Fournié-Zaluski M.-C., Roques B., Darlix J.-L. Viral RNA annealing activities of human immunodeficiency virus type 1 nucleocapsid protein require only peptide domains outside the zinc fingers. Proc. Natl Acad. Sci. USA. 89:1992;6472-6476.
59. 1H NMR structure and biological studies of the His23 to Cys mutant nucleocapsid protein of HIV-1 indicate that the conformation of the first zinc finger is critial for virus infectivity. Biochemistry. 33:1994a;11707-11716.
60. 1H NMR structure of the nucleocapsid protein NCp10 of Moloney murine leukemia virus. J. Biomol. NMR. 4:1994b;153-170.
61. De Guzman R. N., Wu Z. R., Stalling C. C., Pappalardo L., Borer P. N., Summers M. F. Structure of the HIV-1 nucleocapsid protein bound to the SL3 Ψ-RNA recognition element. Science. 279:1998;384-388.
62. Doranz B. J., Rucker J., Yi Y., Smyth R. J., Samson M., Peiper S. C., Parmentier M., Collman R. G., Doms R. W. A dual-tropic primary HIV-1 isolate that uses fusin and the b-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell. 85:1996;1149-1158.
63. Dorfman T., Luban J., Goff S. P., Haseltine W. A., Göttlinger H. G. Mapping of functionally important residues of a cysteine-histidine box in the human immunodeficiency virus type 1 nucleocapsid protein. J. Virol. 67:1993;6159-6169.
64. Dorfman A. T., Bukovsky A., Ohagen A. S., Hoglund H., Gottlinger G. Functional domains of the capsid protein of human immunodeficiency virus type 1. J. Virol. 68:1994a;8180-8187.
65. Dorfman T., Mammano F., Haseltine W. A., Göttlinger H. G. Role of the matrix protein in the virion association of the human immunodeficiency virus type 1 envelope glycoprotein. J. Virol. 68:1994b;1689-1696.
66. Dorn P., DaSilva L., Martarano L., Derse D. Equine infectious anemia virus tat: insights into the structure, function, and evolution of lentivirus trans-activator proteins. J. Virol. 64:1990;1616-1624.
67. Dupraz P., Oertle S., Méric C., Damay P., Spahr P.-F. Point mutations in the proximal Cys-His box of Rous sarcoma virus nucleocapsid protein. J. Virol. 64:1990;4978-4987.
68. Dyda F., Hickman A. B., Jenkins M. T., Engelman A., Craigie R., Davies D. R. Crystal structure of the catalytic domain of HIV-1 integrase: similarity to other polynucleotidyl transferases. Science. 266:1994;1981-1986.
69. Earl P. L., Moss B., Doms R. W. Folding, interaction with GRP78-BiP, assembly, and transport of the human immunodeficiency virus type 1 envelope protein. J. Virol. 65:1991;2047-2055.
70. Ehrlich L. S., Agresta B. E., Carter C. A. Assembly of recombinant human immunodeficiency virus type 1 capsid protein in vitro. J. Virol. 66:1992;4874-4883.
71. Eijkelenboom A. P., Lutzke R. A., Boelens R., Plasterk R. H., Kaptein R., Hard K. The DNA-binding domain of HIV-1 integrase has an SH3-like fold. Nature Struct. Biol. 2:1995;807-810.
72. Emerman M., Malim M. H. HIV-1 regulatory/accessory genes: keys to unraveling viral and host cell biology. Science. 280:1998;1880-1884.
73. Esnouf R., Ren J., Ross R., Jones Y., Stammers D., Stuart D. Mechanism of inhibition of HIV-1 reverse transcriptase by nonnucleoside inhibitors. Nature Struct. Biol. 2:1995;303-308.
74. Fäcke M., Janetzko A., Shoeman R. L., Kräusslich H.-G. A large deletion in the matrix domain of the human immunodeficiency virus gag gene redirects virus particle assembly from the plasma membrane to the endoplasmic reticulum. J. Virol. 67:1993;4972-4980.
75. Farmerie W. G., Loeb D. D., Casavant N. C., Hutchinson C. A. I., Edgell M. H., Swanstrom R. Expression and processing of the AIDS virus reverse transcriptase in Escherichia coli. Science. 236:1987;305-308.
76. Fass D., Harrison S. C., Kim P. S. Retrovirus envelope domain at 1.7 Å resolution. Nature Struct. Biol. 3:1996;465-469.
77. Feng F., Broder C. C., Kennedy P. E., Berger E. A. HIV-1-entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science. 272:1996;872-877.
78. Finzi D., Hermankova M., Pierson T., Carruth L. M., Buck C., Chaisson R. E., Quinn T. C., Chadwick K., Margolick J., Brookmeyer R., Gallant J., Markowitz M., Ho D. D., Richman D. D., Siliciano R. F. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science. 278:1997;1295-1300.
79. Foti M., Mangasarian A., Piguet V., Lew D. P., Krause K. H., Trono D., Carpentier J. L. Nef-mediated clathrin-coated pit formation. J. Cell Biol. 139:1997;37-47.
80. Fouchier R. A., Simon J. H., Jaffe A. B., Malim M. H. Human immunodeficiency virus type 1 Vif does not influence expression or virion incorporation of gag-, pol- and env-encoded proteins. J. Virol. 70:1996;8263-8269.
81. Fouchier R. A. M., Meyer B. E., Simon J. H. M., Fischer U., Malim M. H. HIV-1 infection of non-dividing cells: evidence that the amino-terminal basic region of the viral matrix protein is important for Gag processing but not for post-entry nuclear import. EMBO J. 16:1997;4531-4539.
82. Fouchier R. A. M., Meyer B. E., Simon J. H., Fischer U., Albright A. V., Gonzalez-Siarano F., Malim M. H. J. Virol. 72:1998;6004-6013.
83. Franke E. K., Yuan H. E. H., Bossolt K. L., Goff S. P., Luban J. Specificity and sequence requirements for interactions between various retroviral Gag proteins. J. Virol. 68:1994a;5300-5305.
84. Franke K. E., En Hui Yuan H., Luban J. Specific incorporation of cyclophilin A into HIV-1 virions. Nature. 24:1994b;359-362.
85. Frankel A. D., Biancalana S., Hudson D. Activity of synthetic peptides from the Tat protein of human immunodeficiency virus type 1. Proc. Natl Acad. Sci. USA. 86:1989;7397-7401.
86. Freed E. O., Martin M. A. HIV-1 infection of non-dividing cells. Nature. 369:1994;107-108.
87. Freed E. O., Martin A. M. Virion incorporation of envelope glycoproteins with long but not short cytoplasmic tails is blocked by specific, single amino acid substitutions in the human immunodeficiency virus type 1 matrix. J. Virol. 69:1995;1984-1989.
88. Freed E. O., Martin A. M. Domains of the human immonodeficiency virus type 1 matrix and gp41 cytoplasmic tail required for envelope incorporation into virions. J. Virol. 70:1996;341-351.
89. Freed E. O., Myers D. J., Risser R. Characterization of the fusion domain of the human immunodeficiency virus type 1 envelope glycoprotein gp41. Proc. Natl Acad. Sci. USA. 87:1990;4650-4654.
90. Freed E. O., Orenstein J. M., Buckler-White A. J., Martin M. A. Single amino acid changes in the human immunodeficiency virus type 1 matrix protein block virus particle production. J. Virol. 68:1994;5311-5320.
91. Freed E. O., Englund G., Martin A. M. Role of the basic domain of human immondeficiency virus type 1 matrix in macrophage infection. J. Virol. 69:1995;3949-3954.
92. Freed E. O., Englund G., Maldarelli F., Martin M. A. Phosphorylation of residue 131 of HIV-1 matrix is not required for macrophage infection. Cell. 88:1997;171-173.
93. Le Gall S., Erdtmann L., Benichou S., Berlioz-Torrent C., Liu L., Benarous R., Heard J. M., Schwartz O. Nef interacts with the mu subunit of clathrin adaptor complexes and reveals a cryptic sorting signal in MHC I molecules. Immunity. 8:1998;483-495.
94. Gallay P., Swingler S., Aiken C., Trono D. HIV-1 infection of nondividing cells: C-terminal tyrosine phosphorylation of the viral matrix protein is a key regulator. Cell. 80:1995a;379-388.
95. Gallay P., Swingler S., Song J., Bishman F., Trono D. HIV nuclear import is governed by the phosphotyrosine-mediated binding of matrix to the core domain of integrase. Cell. 83:1995b;569-576.
96. Gallo R. C., Salahuddin S. Z., Popovic M., Shearer G. M., Kaplan M., Haynes B. F., Palker T. J., Redfield R., Oleske J., Safai B., White G., Foster P., Markham P. D. Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. Science. 224:1984;500-503.
97. Gamble T. R., Vajdos F., Yoo S., Worthylake D. K., Houseweart S. M., Sundquist W. I., Hill C. P. Crystal structure of human cyclophilin A bound to the amino-terminal domain of the HIV-1 capsid. Cell. 87:1996;1285-1294.
98. Gamble T. R., Yoo S., Vajdos F. F., von Schwedler U. K., Korthylake D. K., Wang H., McCutcheon J. P., Sundquist W. I., Hill C. P. Structure of the carboxyl-terminal dimerization domain of the HIV-1 capsid protein. Science. 278:1997;849-853.
99. Gao Y., Kaluarachchi K., Griedroc D. P. Solution structure and backbone dynamics of Mason-Pfizer monkey virus nucleocapsid protein. Protein Sci. 7:1998;2265-2280.
100. gagvirus-like particles from recombinant baculovirus-infected insect cells. Cell. 59:1989;103-112.
101. Gilbona E., Mitra S. W., Goff S., Baltimore D. A detailed model of reverse transcription and tests of crucial aspects. Cell. 18:1979;93-100.
102. Gitti R. K., Lee B. M., Walker J., Summers M. F., Yoo S., Sundquist W. I. Structure of the amino-terminal core domain of the HIV-1 capsid protein. Science. 273:1996;231-235.
103. Goff S. P. Retroviral reverse transcriptase: synthesis, structure and function. J. Aquired Immune Defic. Syndr. 3:1990;817-831.
104. Goldsmith M. A., Warmerdam M. T., Atchison R. E., Miller M. D., Greene W. C. Dissociation of the CD4 downregulation and viral infectivity enhancement functions of human immunodeficiency virus type 1 Nef. J. Virol. 69:1995;4112-4121.
105. Goncalves J., Korin Y., Zack J., Gabuzda D. Role of vif in human immunodeficiency virus type 1 reverse transcriptase. J. Virol. 70:1996;8701-8709.
106. Gorelick R. J., Henderson L. E., Hanser J. P., Rein A. Point mutants of Moloney murine leukemia virus that fail to package viral RNA: evidence for specific RNA recognition by a "zinc finger-like" protein sequence. Proc. Natl Acad. Sci. USA. 85:1988;8420-8424.
107. Gorelick R. J., Nigida J., Stephen M., Bess J. W., Arthur L. O., Henderson L. E., Alan R. Noninfectious human immunodeficiency virus type 1 mutants deficient in genomic RNA. J. Virol. 64:1990;3207-3211.
108. Gorelick R. J., Chabot D. J., Alan R., Henderson L. E., Arthur L. O. The two zinc fingers in the human immunodeficiency virus type 1 nucleocapsid protein are not functionally equivalent. J. Virol. 67:1993;4027-4036.
109. Göttlinger H. G., Sodroski J. G., Haseltine W. A. Role of capsid precursor processing and myristoylation in morphogenesis and infectivity of human immunodeficiency virus type 1. Proc. Natl Acad. Sci. USA. 86:1989;5781-5785.
110. Green L. M., Berg J. M. A retroviral Cys-Xaa2-Cys-Xaa4-His-Xaa4-Cys peptide binds metal ions: spectoscopic studies and a proposed three-dimensional structure. Proc. Natl Acad. Sci. USA. 86:1989;4047-4051.
111. Green L. M., Berg J. M. Retroviral nucleocapsid protein-metal ion interactions: folding and sequence variants. Proc. Natl Acad. Sci. USA. 87:1990;6403-6407.
112. Greenberg M. E., Bronson S., Lock M., Neumann M., Pavlakis G. N., Skowronski J. EMBO J. 16:1997;6964-6976.
113. Gross I., Hohenberg H., Juckhagel C., Krausslich H.-G. N-terminal extension of human immunodeficiency virus capsid protein converts the in vitro assembly phenotype from tubular to spherical particles. J. Virol. 72:1998;4798-4810.
114. Grzesiek S., Bax A., Nicholson L. K., Yamazaki T., Wingfield P., Stahl S. J., Eyermann C. J., Torchia D. A., Hodge C. N., Lam P. Y. S., Jadhav P. K., Chang C.-H. NMR evidence for the displacement of a conserved interior water molecule in HIV protease by a non-peptide cyclic urea-based inhibitor. J. Am. Chem. Soc. 116:1994;1581-1582.
115. Grzesiek S., Bax A., Clore G. M., Gronenborn A. M., Hu J.-S., Kaufman J., Palmer I., Stahl S. J., Wingfield P. T. The solution structure of HIV-1 Nef reveals an unexpected fold and permits delineation of the binding surface for the SH3 domain of Hck tyrosine protein kinase. Nature Struct. Biol. 3:1996;340-345.
116. Grzesiek S., Bax A., Hu J.-S., Kaufman J., Palmer I., Stahl S. J., Tjandra N., Wingfield P. T. Refined solution structure and backbone dynamics of HIV-1 Nef. Protein Sci. 6:1997;1248-1263.
117. Gulick R. M., Mellors J. W., Havlir D., Eron J. J., Gonzalez C., McMahon D., Richman D. D., Valentine F. T., Jonas L., Meibohm A., Emini E. A., Chodakewitz J. A. Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy. New Eng. J. Med. 337:1997;734-739.
118. Gustchina A., Kervinen J., Powell D. J., Zdanov A., Kay J., Wlodawer A. Structure of equine infectious anemia virus proteinase complexed with an inhibitor. Protein Sci. 5:1996;1453-1465.
119. Harrison G. P., Lever A. M. L. The human immunodeficiency virus type 1 packaging signal and major splice donor region have a conserved stable secondary structure. J. Virol. 66:1992;4144-4153.
120. Hayashi T., Shioda T., Iwakura Y., Shibuta H. RNA packaging signal of human immunodeficiency virus type 1. Virology. 188:1992;590-599.
121. Hayashi T., Ueno Y., Okamoto T. Elucidation of a conserved RNA stem-loop structure in the packaging signal of human immunodeficiency virus type 1. FEBS Letters. 327:1993;213-218.
122. Heaphy S., Finch J. T., Gait M. J., Karn J., Singh M. Human immunodeficiency virus type 1 regulator of virion expression, rev, forms nucleoprotein filaments after binding to a purine rich bubble located within the rev response region of viral mRNAs. Proc. Natl Acad. Sci. USA. 88:1991;7366-7370.
123. Henderson L. E., Copeland T. D., Sowder R. C., Smythers G. W., Oroslzan S. Primary structure of the low molecular weight nucleic acid-binding proteins of murine leukemia viruses. J. Biol. Chem. 256:1981;8400-8406.
124. Herrmann C. H., Rice A. P. Lentivirus Tat proteins specifically associate with a cellular protein kinase, TAK, that hyperphosphorylates the carboxyl-terminal domain of the large subunit of RNA polymerase II: candidate for a Tat co-factor. J. Virol. 69:1995;1612-1620.
125. Hill C. P., Worthylake D., Bancroft D. P., Christensen A. M., Sundquist W. I. Crystal structures of the trimeric HIV-1 matrix protein: implications for membrane association. Proc. Natl Acad. Sci. USA. 93:1996;3099-3104.
126. Ho D. D., Neumann A. U., Perelson A. S., Chen W., Leonard J. M., Markowitz M. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature. 373:1995;123-126.
127. Hockley D. J., Nermut M. V., Grief C., Jowett J. B. M., Jones I. M. Comparative morphology of Gag protein structures produced by mutants of the gag gene of human immunodeficiency virus type 1. J. Gen. Virol. 75:1994;2985-2997.
128. Hogle J. M., Chow M., Filman D. J. Three-dimensional structure of poliovirus at 2.9 Å resolution. Science. 229:1985;1358-1365.
129. Hong S. S., Boulanger P. Assembly-defective point mutants of the human immunodeficiency virus type 1 Gag precursor phenotypically expressed in recombinant baculovirus-infected cells. J. Virol. 67:1993;2787-2798.
130. Hoxie J. A., Alpers J. D., Rackowski J. L., Huebner K., Haggarty B. S., Cedarbaum A. J., Reed J. C. Alterations in T4 (CD4) protein and mRNA synthesis in cells infected with HIV. Science. 234:1986;1123-1127.
131. Hsiou Y., Ding J., Das K., Clark A. D. Jr, Hughes S. H., Arnold E. Structure of unliganded HIV-1 reverse transcriptase at 2.7 Å resolution: implications of conformational changes for polymerization and inhibition mechanisms. Structure. 4:1996;853-860.
132. Ippolito J. A., Steitz T. A. A 1.3 Å resolution crystal structure of the HIV-1 trans-activation response region RNA stem reveals a metal ion-dependent bulge conformation. Proc. Natl Acad. Sci. USA. 95:1998;9819-9824.
133. Jacks T., Power M. D., Masiarz F. R., Luciw P. A., Barr P. J., Varmus H. E. Characterization of ribosomal frameshifting in HIV-1 gag-pol expression. Nature. 331:1988;280-283.
134. Jacobo-Molina A., Ding J., Nanni R. G., Clark A. D. Jr, Lu X., Tantillo C., Williams R. L., Kamer G., Ferris A. L., Clark P., Hizi A., Hughes S. H., Arnold E. Crystal structure of human immunodeficiency virus type 1 reverse transcriptase complexed with double-stranded DNA at 3.0 Å resolution shows bent DNA. Proc. Natl Acad. Sci. USA. 90:1993;6320-6324.
135. Jenkins T. M., Hickman A. B., Dyda F., Ghirlando R., Davies D. R., Craigie R. A soluble active mutant of HIV-1 integrase: involvement of both the core and carboxyl terminal domains in multimerization. J. Biol. Chem. 271:1996;7712-7718.
136. Jentoft J. E., Smith L. M., Fu X., Johnson M., Leis J. Conserved cysteine and histidine residues of the avian myeloblastosis virus nucleocapsid protein are essential for viral replication but are not "zinc-binding fingers" Proc. Natl Acad. Sci. USA. 85:1988;7094-7098.
137. Jones K. A., Peterlin B. M. Control of RNA initiation and elongation at the HIV-1 promoter. Annu. Rev. Biochem. 63:1994;717-743.
138. Jowett J., Hockley D., Nermut M. V., Jones I. M. Distinct signals in human immunodeficiency virus type 1 Pr55 necessary for RNA binding and particle formation. J. Gen. Virol. 73:1992;3079-3086.
139. Jowett J. B. M., Planelles V., Poon B., Shah N. P., Chen M.-L., Chen I. S. Y. The human immunodeficiency virus type 1 vpr gene arrests infected T cells in the G2+M phase of the cell cycle. J. Virol. 69:1995;6304-6313.
140. 1H NMR-derived 3D structure and to a loss of biological activity. FEBS Letters. 331:1993;43-48.
141. Katz R. A., Skalka A. M. The retroviral enzymes. Annu. Rev. Biochem. 63:1994;133-173.
142. Kestler H. W. I., Ringler D. J., Mori K., Panicali D. L., Sehgal P. K., Daniel M. D., Desrosiers R. C. Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell. 65:1991;651-662.
143. Kirchoff F., Greenough T. C., Brettler D. B., Sullivan J. L., Desrosiers R. C. Absence of intact nef sequences in a long-term servivor with nonprogressive HIV-1 infection. New Eng. J. Med. 332:1995;228-232.
144. Kjems J., Calnan B. J., Frankel A., Sharp P. A. Specific binding of a basic peptide from HIV-1 Rev. EMBO J. 11:1992;1119-1129.
145. Kohlstaedt L. A., Wang J., Friedman J. M., Rice P. A., Steitz T. A. Crystal structure at 3.5 Å resolution of HIV-1 reverse transcriptase complexed with an inhibitor. Science. 256:1992;1783-1790.
146. Kohlstaedt L. A., Wang J., Rice P. A., Friedman J. M., Steitz T. A. The structure of HIV-1 reverse transcriptase. Skalka A. M., Goff S. P. Reverse Transcriptase. 1993;223-249 Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
147. Koken S. E., Greijer A. E., Verhoef K., van Wamel J., Burrinskaya A. G., Berkhout B. Intracellular analysis of in vitro modified HIV Tat protein. J. Biol. Chem. 269:1994;8366-8375.
148. Kondo E., Gottlinger H. G. A conserved LXXLF sequence is the major determinant in p6gag required for the incorporation of human immunodeficiency virus type 1 Vpr. J. Virol. 70:1996;159-164.
149. Kong L. B., An D., Ackerson B., Canon J., Rey O., Chen I. S. Y., Krogstad P., Steward P. L. Cryoelectron microscopy examination of human immunodeficiency virus type-1 virions with mutations in the cyclophilin A binding loop. J. Virol. 72:1998;4403-4407.
150. Kowalski M., Potz J., Basiripour L., Dorfman T., Goh W. C., Terwilliger E., Dayton A., Rosen C., Haseltine W., Sodroski J. Functional regions of the envelope glycoprotein of human immunodeficiency virus type 1. Science. 237:1987;1351-1355.
151. Kwong P. D., Wyatt R., Robinson J., Sweet R. W., Sodroski J., Hendrickson W. A. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature. 393:1998;648-659.
152. Lam P. Y. S., Jadhav P. K., Eyermann C. J., Hodge C. N., Ru Y., Bacheler L. T., Meek J. L., Otto M. J., Rayner M. M., Wong Y. N., Chang C.-H., Weber P. C., Jackson D. A., Sharpe T. R., Erickson-Viitanen S. Rational design of potent, bioavailable, nonpeptide cyclic ureas as HIV protease inhibitors. Science. 263:1994;380-384.
153. Langedijk J. P. M., Schalken J. J., Tersmette M., Huisman J. G., Meloen R. H. Location of epitopes on the major core protein p24 of human immunodeficiency virus. J. Gen. Virol. 71:1990;2609-2614.
154. Lapadat-Tapolsky M., De Rocquigny H., Van Gent D., Roques B., Plasterk R., Darlix J.-L. Interactions between HIV-1 nucleocapsid protein and viral DNA may have important functions in the viral life cycle. Nucl. Acids Res. 21:1993;831-839.
155. Lee B. M., De Guzman R. N., Turner B. G., Tjandra N., Summers M. F. Dynamical behavior of the HIV-1 nucleocapsid protein. J. Mol. Biol. 279:1998;633-649.
156. Lee C.-H., Saksela K., Mirza U. A., Chait B. T., Kuriyan J. Crystal structure of the conserved core of HIV-1 Nef complexed with a Src family SH3 domain. Cell. 85:1996;931-942.
157. Le Grice S. F. J., Naas T., Wohlgensinger B., Schatz O. Subunit-selective mutagenesis indicates minimal polymerase activity in heterodimer associated p51 of HIV-1 reverse transcriptase. EMBO J. 10:1991;3905-3911.
158. Leonard C. K., Spellman M. W., Riddle L., Harris R. J., Thomas J. N., Gregory T. J. Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cell. J. Biol. Chem. 265:1990;10373-10382.
159. Levy J. A., Hoffmann A. D., Kramer S. M., Landis J. A., Shimabukuro J. M., Oshiro L. S. Recovery of AIDS-associated retroviruses from patients with AIDS or AIDS-related conditions and from clinically healthy individuals. J. Infect. Dis. 152:1984;734-738.
160. Liu H., Wu X., Newman M., Shaw G. M., Hahn B. H., Kappes J. C. The Vif
161. Lodi P. J., Ernst J. A., Kuszewski J., Hickman A. B., Engelman A., Craigie R., Clore G. M., Gronenborn A. M. Solution structure of the DNA binding domain of HIV-1 integrase. Biochemistry. 34:1995;9826-9833.
162. Lu M., Blacklow S. C., Kim P. S. A trimeric structural domain of the HIV-1 transmembrane glycoprotein. Nature Struct. Biol. 2:1995;1075-1082.
163. Luban J., Bossolt K. L., Franke E. K., Kalpana G. V., Goff S. P. Human immunodeficiency virus type 1 gag protein binds to cyclophilins A and B. Cell. 73:1993;1067-1078.
164. Luban J., Franke E. K., Yuan H. E. HIV-1 uses host-cell proteins to form fully infectious virions. Nature. 7:1994;37-42.
165. Malim M. H., Cullen B. R. HIV-1 structural gene expression requires the binding of multiple rev monomers to the viral RRE: implications for HIV-1 latency. Cell. 65:1991;241-248.
166. Malim M. H., Bohnlein S., Hauber J., Cullen B. R. Functional dissection of the HIV-1 Rev trans-activator - derivation of a trans-dominant repressor of Rev function. Cell. 58:1989a;205-214.
167. Malim M. H., Hauber J., Le S. Y., Maizel J. V., Cullen B. R. The HIV-1 rev transactivator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA. Nature. 338:1989b;254-257.
168. Malim M. H., Tiley L. S., McCarn D. F., Rusche J. R., Hauber J., Cullen B. R. HIV-1 structural gene expression requires binding of the Rev trans-activator to its RNA target sequence. Cell. 60:1990;675-683.
169. Mammano F., Kondo E., Sodroski J., Bukovsky A., Gottlinger H. G. Rescue of human immunodeficiency virus type 1 matrix protein mutants by envelope glycoproteins with short cytoplasmic domains. J. Virol. 69:1995;3824-3830.
170. Mangasarian A., Trono D. The multifaceted role of HIV Nef. Res. Virol. 148:1997;30-33.
171. Margottin F., Bour S. P., Durand H., Selig L., Benichou S., Richard V., Thomas D., Strebel K., Benarous R. A novel human WD protein, h-beta TrCp, that interacts with the HIV-1 Vpu connects CD4 to the ER degradation pathway through an F-box motif. Mol. Cell. 1:1998;565-574.
172. Massiah M. A., Starich M. R., Paschall C., Summers M. F., Christensen A. M., Sundquist W. I. Three-dimensional structure of the human immunodeficiency virus type 1 matrix protein. J. Mol. Biol. 244:1994;198-223.
173. Massiah M. A., Worthylake D., Christensen A. M., Sundquist W. I., Hill C. P., Summers M. F. Comparison of the NMR and X-ray structures of the HIV-1 matrix protein: evidence for conformational changes during viral assembly. Protein Sci. 5:1996;2391-2398.
174. Matthews S., Barlow P., Boyd J., Barton G., Russell R., Mills H., Cunningham M., Meyers N., Burns N., Clark N., Kingsman S., Kingsman A., Campbell I. Structural similarity between the p17 matrix protein of HIV-1 and interferon-γ Nature. 370:1994;666-668.
175. Matthews S., Barlow P., Clark N., Kingsman S., Kingsman A., Campbell I. Refined solution structure of p17, the HIV matrix protein. Biochem. Soc. Trans. 23:1995;725-728.
176. Matthews S., Mikhailov M., Burny A., Roy P. The solution structure of the bovine leukemia virus matrix protein and similarity with lentiviral matrix proteins. EMBO J. 15:1996;3267-3274.
177. McBride M. S., Panganiban A. T. The human immunodeficiency virus type 1 encapsidation site is a multipartite RNA element composed of functional hairpin structures. J. Virol. 70:1996;2963-2973.
178. Mély Y., Cornille F., Fournié-Zaluski M.-C., Darlix J.-L., Roques B. P., Gérard D. Investigation of zinc-binding affinities of moloney murine leukemia virus nucleocapsid protein and its related zinc finger and modified peptides. Biopolymers. 31:1991;899-906.
179. Mély Y., de Rocquigny H., Piémont E., Déméné H., Julian N., Fournié-Zaluski M.-C., Roques B. P., Gérard D. Influence of the N- and C-terminal chains on the zinc-binding and conformational properties of the central zinc-finger structure of Moloney murine leukemia virus nucleocapsid protein: a steady-state and time-resolved fluorescence study. Biochim. Biophys. Acta. 1161:1993a;6-18.
180. Phebinding: a steady-state and time resolved fluorescence study. Biophys. J. 65:1993b;1513-1522.
181. Mély Y., De Rocquigny H., Morellet N., Roques B. P., Gérard D. Zinc binding to the HIV-1 nucleocapsid protein: a thermodynamic investigation by fluorescence spectroscopy. Biochemistry. 35:1996;5175-5182.
182. Méric C., Goff S. P. Characterization of Moloney murine leukemia virus mutants with single-amino-acid substitutions in the Cys-His box of the nucleocapsid protein. J. Virol. 63:1989;1558-1568.
183. Méric C., Gouilloud E., Spahr P.-F. Mutations in Rous sarcoma virus nucleocapsid protein p12 (NC): deletions of Cys-His Boxes. J. Virol. 62:1988;3328-3333.
184. Miller M., Jaskolski M., Rao Mohana J. K., Leis J., Wlodawer A. Crystal structure of a retroviral protease proves relationship to aspartic protease family. Nature. 337:1989a;576-579.
185. Miller M., Schneider J., Sathyanarayana B. K., Toth M. V., Marshall G. R., Clawson L., Selk L., Kent S. B. H., Wlodawer A. Structure of a complex of synthetic HIV-1 protease with a substrate-based inhibitor at 2.3 Å resolution. Science. 246:1989b;1149-1152.
186. Miller M. D., Farnet C. M., Bushman F. D. Human immunodeficiency virus type 1 preintegration complexes: studies of organization and composition. J. Virol. 71:1997;5382-5390.
187. Moebius U., Clayton L., Abraham S., Harrison S., Reinhertz E. The human immunodeficiency virus gp120 binding site of CD4: delineation by quantitative equilibrium and kinetic binding studies of mutants in conjunction with a high-resolution CD4 atomic structure. J. Exp. Med. 176:1992;507-517.
188. Momany C., Kovari L. C., Prongay A. J., Keller W., Gitti R. K., Lee B. M., Gorbalenya A. E., Tong L., McClure J., Ehrlich L. S., Summers M. F., Carter C., Rossmann M. G. Crystal structure of dimeric HIV-1 capsid protein. Nature Struct. Biol. 9:1996;763-770.
189. Moore J. P. Coreceptors: implications for HIV pathogenesis and therapy. Science. 276:1997;51-52.
190. 1H NMR. EMBO J. 11:1992;3059-3065.
191. 1H NMR. J. Mol. Biol. 235:1994;287-301.
192. Mujeeb A., Bishop K., Peterlin B. M., Turck C., Parslow T. G., James T. L. NMR structure of a biologically active peptide containing the RNA-binding domain of human immunodeficiency virus type 1 Tat. Proc. Natl Acad. Sci. USA. 91:1994;8248-8252.
193. Mulichak A. M., Hui J. O., Tomasselli A. G., Heinrikson R. L., Curry K. A., Tomich C. S., Thaisrivongs S., Sawyer T. K., Watenpaugh K. D. The crystallographic structure of the protease from human immunodeficiency virus type 2 with two synthetic peptidic transition state analog inhibitors. J. Biol. Chem. 268:1993;13103-13109.
194. Navia M. A., Fitzgerald P. M. D., McKeever B. M., Leu C.-T., Heimbach J. C., Herber W. K., Sigal I. S., Darke P. L., Springer J. P. Three-dimensional structure of aspartyl protease from human immunodeficiency virus HIV-1. Nature. 337:1989;615-620.
195. Nermut M. V., Thomas D. Fullerene-like organization of HIV gag-protein shell in virus-like particles produced by recombinant baculovirus. Virology. 198:1994;288-296.
196. Nermut M. V., Grief C., Hashmi S., Hockley D. J. Further evidence of icosahedral symmetry in human and simian immunodeficiency virus. AIDS Res. Hum. Retrovir. 9:1993;929-938.
197. Nicholson L. K., Yamazaki T., Torchia D. A., Grzesiek S., Bax A., Kaufman J. D., Stahl S. J., Wingfield P., Lam P. Y. S., Jadhav P. K., Hodge C. N., Domaille P. J., Chong-Hwan C. Flexibility and function in HIV-1 protease. Nature Struct. Biol. 2:1995;274-280.
198. Nie Z., Bergeron D., Subbramanian R. A., Yao X.-J., Checroune F., Rougeau N., Cohen E. A. The putative alpha helix 2 of human immunodeficiency virus type-1 Vpr contains a determinant which is responsible for the nuclear translocation of proviral DNA in growth-arrested cells. J. Virol. 72:1998;4104-4115.
199. Ohno M., Fornerod M., Mattaj I. W. Nucleocytoplasmic transport: the last 200 nanometers. Cell. 92:1998;327-336.
200. Olshevsky U., Helseth E., Furman C., Li J., Haseltine W., Sodroski J. Identification of individual human immunodeficiency virus type 1 gp120 amino acids important for CD4 receptor binding. J. Virol. 64:1990;5701-5707.
201. Omichinski J. G., Clore G. M., Sakaguchi K., Appella E., Gronenborn A. M. Structural characterization of a 39-residue synthetic peptide containing the two zinc binding domains from the HIV-1 p7 nucleocapsid protein by CD and NMR spectroscopy. FEBS Letters. 292:1991;25-30.
202. Perelson A. S., Neumann A. U., Markowitz M., Leonard J. M., Ho D. D. HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science. 271:1996;1582-1586.
203. Piguet V., Chen Y. L., Mangasarian A., Foti M., Carpentier J. L., Trono D. Mechanism of Nef-induced CD4 endocytosis: Nef connects CD4 with the mu chain of adaptor complexes. EMBO J. 17:1998;2472-2481.
204. Pollard V. W., Malim M. H. Annu. Rev. Microbiol. 1998.
205. Popov S., Rexach M., Zybarth G., Reiling N., Lee M. A., Ratner L., Lane C. M., Moore M. S., Blobel G., Bukrinsky M. Viral protein R regulates nuclear import of the HIV-1 pre-integration complex. EMBO J. 17:1998;909-917.
206. Powers R., Clore G. M., Bax A., Garrett D. S., Stahl S. J., Wingfield P. T., Gronenborn A. M. Secondary structure of the ribonuclease H domain of the human immunodeficiency virus reverse transcriptase in solution using three-dimensional double and triple resonance heteronuclear magnetic resonance spectroscopy. J. Mol. Biol. 221:1991;1081-1090.
207. 15N relaxation measurements. Biochemistry. 31:1992;9150-9157.
208. Profy A. T., Salinas P. A., Eckler L. I., Dunlop N. M., Nara P. L., Putney S. D. Epitopes recognized by the neutralizing antibodies of an HIV-1-infected individual. J. Immunol. 144:1990;4641-4647.
209. Puglisi J. D., Tan R., Calnan B. J., Frankel A. D., Williamson J. R. Conformation of the TAR RNA-arginine complex by NMR spectroscopy. Science. 257:1992;76-80.
210. Puras-Lutzke R. A., Vink C., Plasterk R. H. A. Characterization of the minimal DNA-binding domain of the HIV integrase protein. Nucl. Acids Res. 22:1994;4125-4131.
211. Rao Z., Belyaev A. S., Fry E., Roy P., Jones I. M., Stuart D. I. Crystal structure of SIV matrix antigen and implications for virus assembly. Nature. 378:1995;743-747.
212. Re F., Braaten D., Franke E. K., Luban J. Human immunodeficiency virus type 1 Vpr arrests the cell cycle in G2 by inhibiting the activation of p34-cdc2-cyclin B. J. Virol. 69:1995;6859-6864.
213. Reicin A. S., Paik S., Berkowitz R. D., Luban J., Lowy I., Goff S. P. Linker insertion mutations in the human immunodeficiency virus type 1 gag gene: effects on virion particle assembly, release, and infectivity. J. Virol. 69:1995;642-650.
214. Reil H., Bukovsky A. A., Gelderblom H. R., Gottlinger H. G. Efficient HIV-1 replication can occur in the absence of the viral matrix protein. EMBO J. 17:1998;2699-2708.
215. Reines D., Conaway J. W., Conaway R. C. The RNA polymerase II general elongation factors. Biochem. Sci. 9:1996;351-355.
216. Ren J., Esnouf R., Garman E., Somers D., Ross C., Kirby I., Keeling J., Darby G., Jones Y., Stuart D., Stammers D. High resolution structures of HIV-1 RT from four RT-inhibitor complexes. Nature Struct. Biol. 2:1995;293-302.
217. Rice A. P., Chan F. Tat protein of human immunodeficiency virus type 1 is a monomer when expressed in mammalian cells. Virology. 185:1991;451-454.
218. Rice W. G., Turpin J. A. Virus-encoded zinc fingers as targets for antiviral chemotherapy. Revs. Med. Virol. 6:1996;187-199.
219. Rice W. G., Schaeffer C. A., Graham L., Bu M., McDougal J. S., Orloff S. L., Villinger F., Young M., Oroszlan S., Fesen M. R., Pommier Y., Mendeleyev J., Kun E. The site of antiviral action of 3-nitrosobenzamide on the infectivity process of human immunodeficiency virus in human lymphocytes. Proc. Natl Acad. Sci. USA. 90:1993a;9721-9724.
220. Rice W. G., Schaeffer C. A., Harten B., Villinger F., South T. L., Summers M. F., Henderson L. E., Bess J. W. Jr, Arthur L. O., McDougal J. S., Orloff S. L., Mendeleyev J., Kun E. Inhibition of HIV-1 infectivity by zinc-ejecting aromatic C -nitroso compounds. Nature. 361:1993b;473-475.
221. Rice W. G., Supko J. G., Malspeis L., Buckheit J. R. W., Clanton D., Bu M., Grahm L., Schaeffer C. A., Turpin J. A., Domagala J., Gogliotti R., Bader J. P., Halliday S. M., Coren L., Sowder R. C. II, Arthur L. O., Henderson L. E. Inhibitors of HIV nucleocapsid protein zinc fingers as candidates for the treatment of AIDS. Science. 270:1995;1194-1197.
222. Rice W. G., Turpin J. A., Clanton D., Buckheit R. W. Jr, Summers M. F., McDonnell N., DeGuzman R. N., Covell D. G., Wallqvist A., Zalkow L., Bader J. P., Haugwitz R. D., Sausville E. A. Azodicarbonamide inhibits HIV-1 replication by targeting the nucleocapsid protein. Nature Med. 3:1997;341-345.
223. Robert-Hebmann V., Emiliani S., Jean F., Resnicoff M., Traincard F., Devaux C. Clonal analysis of murine B cell response to the human immunodeficiency virus type 1 (HIV-1)-gag p17 and p25 antigens. Mol. Immunol. 29:1992;729-738.
224. Rodgers D. W., Gamblin S. J., Harris B. A., Ray S., Culp J. S., Hellmig B., Woolf D. J., Debouck C., Harrison S. C. The structure of unliganded reverse transcriptase from the human immunodeficiency virus type 1. Proc. Natl Acad. Sci. USA. 92:1995;1222-1226.
225. Rogel M. E., Wu L. I., Emerman M. The human immunodeficiency virus type 1 vpr gene prevents cell proliferation during chronic infection. J. Virol. 69:1995;882-888.
226. Rose R. B., Rose J. R., Salto R., Craik C. S., Stroud R. M. Structure of the protease from simian immunodeficiency virus: complex with an irreversible nonpeptide inhibitor. Biochemistry. 32:1993;12498-12507.
227. Rose S., Hensley P., O'Shannessy D. J., Culp J., Debouck C., Chaiken I. Characterization of HIV-1 p24 self-association using analytical affinity chromatography. Proteins: Struct. Funct. Genet. 13:1992;112-119.
228. Rossmann M. G. Antiviral agents targeted to interact with viral capsid proteins and a possible application to human immunodeficiency virus. Proc. Natl Acad. Sci. USA. 85:1988;4625-4627.
229. Rossmann M. G. The canyon hypothesis. Viral Immunol. 2:1989;143-161.
230. Rossmann M. G., Johnson J. E. Icosahedral RNA virus structure. Annu. Rev. Biochem. 58:1989;533-573.
231. Rossmann M. G., Arnold E., Erickson J. W., Frankenberger E. A., Griffith J. P., Hecht H. J., Johnson J. E., Kamer G., Luo M., Mosser A. G., Rueckert R. R., Sherry B., Vriend G. Structure of a human common cold virus and functional relationship to other picornaviruses. Nature. 317:1985;145-153.
232. Ryu S.-E., Truneh A., Sweet R. W., Hendrickson W. A. Structure of an HIV and MHC binding fragment from human CD4 as refined in two crystal lattices. Structure. 2:1994;59-74.
233. Sakaguchi K., Zambrano N., Baldwin E. T., Shapiro B. A., Erickson J. W., Omichinski J. G., Clore G. M., Gronenborn A. M., Appella E. Idenification of a binding site for the human immunodeficiency virus type 1 nucleocapsid protein. Proc. Natl Acad. Sci. USA. 90:1993;5219-5223.
234. Saksela K., Cheng G., Baltimore D. Proline-rich (PxxP) motifs in HIV-1 Nef bind to SH3 domains of a subset of Src kinases and are required for the enhanced growth of Nef+ viruses but not for down-regulation of CD4. EMBO J. 14:1995;484-491.
235. Salghetti S., Mariani R., Skowronski J. Human immunodeficiency virus type 1Nef and p56lck protein-tyrosine kinase interact with a common element in CD4 cytoplasmic tail. Proc. Natl Acad. Sci. USA. 92:1995;349-353.
236. Sattentau Q., Moore J. Conformational changes induced in the human immunodeficiency virus envelope glycoprotein by soluble CD4 binding. J. Expt. Med. 174:1991;407-415.
237. Sattentau Q. J., Moore J. P., Vignaux F., Traincard F., Poignard P. Conformational changes induced in the envelope glycoproteins of the human and simian immunodeficiency viruses by soluble receptor binding. J. Virol. 67:1993;7383-7398.
238. Sawai E. T., Baur A., Struble H., Peterlin B. M., Levy J. A., Cheng-Mayer C. Human immunodeficiency virus type 1 Nef associates with a cellular serine kinase in T lymphocytes. Proc. Natl Acad. Sci. USA. 91:1994;1539-1543.
239. Schubert U., Antón L. C., Bacik J., Cox J. H., Bour S., Bennick J. R., Orlowski M., Strebel K., Yewdell J. W. CD4 glycoprotein degradation induced by human immuno-deficiency virus type I Vpu protein requires the function of proteosomes and the ubiquitin-conjugating pathway. J. Virol. 72:1998;2280-2288.
240. Schwartz O., Marechal V., Danos O., Heard J.-M. Human immunodeficiency virus type 1 nef increases the efficiency of reverse transcription in the infected cell. J. Virol. 69:1995;4053-4059.
241. Shailer P., Brodfuehrer J., Sedman A., Vassos A. Single-dose safety, tolerance, and pharmacokinetics of CI-1012, a new HIV antiretroviral agent, in healthy volunteers. Proceedings: Fourth Conference on Retroviruses and Opportunistic Infections. 1997.
242. Shoji S., Tashiro A., Kubota Y. Antimyristoylation of gag proteins in human T-cell lymphotropic and human imunodeficiency viruses by N-myristoyl glycinal diethylacetal. Ann. N. Y. Acad. Sci. 616:1990;97-115.
243. Simon J. H., Miller D. L., Fouchier R. A., Soares M. A., Peden K. W., Malim M. H. The regulation of primate immunodeficiency virus infectivity by Vif is cell species restricted: a role for Vif in determining virus host range and cross-species transmission. EMBO J. 17:1998;1259-1267.
244. Skalka A. M., Goff S. P. Reverse Transcriptase. 1993;Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
245. Slice L. W., Codner E., Antelman D., Holly M., Wegrzynski B., Wang J., Toome V., Hsu M. C., Nalin C. M. Characterization of recombinant HIV-1 Tat and its interaction with TAR RNA. Biochemistry. 31:1992;12062-12068.
246. Smerdon S. J., Jager J., Wang J., Kohlstaedt L. A., Chirino A. J., Friedman J. M., Rice P. A., Steitz T. A. Structure of the binding site for nonnucleoside inhibitors of the reverse transcriptase of human immunodeficiency virus type-1. Proc. Natl Acad. Sci. USA. 91:1994;3911-3915.
247. Smith T. J., Kremer M. J., Luo M., Vriend G., Arnold E., Kamer G., Rossmann M. G., McKinlay M. A., Diana G. D., Otto M. J. The site of attachment in human rhinovirus 14 for antiviral agents that inhibit uncoating. Science. 233:1986;1286-1293.
248. Sourgen F., Maroun R. G., Frere V., Bouziane M., Aucoair C., Troalen F., Fermandjian S. A synthetic peptide from the human immunodeficiency virus type-1 integrase exhibits coiled-coil properties and interferes with the in vitro integration activity of the enzyme. Eur. J. Biochem. 240:1996;765-773.
249. South T. L., Summers M. F. Zinc- and sequence-dependent binding to nucleic acids by the N-terminal zinc finger of the HIV-1 nucleocapsid protein: NMR structure of the complex with the Psi-site analog, dACGCC. Protein Sci. 2:1993;3-19.
250. South T. L., Kim B., Summers M. F. 113Cd NMR studies of a 1:1 Cd adduct with an 18-residue zinc finger peptide from HIV-1 nucleic acid binding protein, p7. J. Am. Chem. Soc. 111:1989;395-396.
251. South T. L., Kim B., Hare D. R., Summers M. F. Zinc fingers and molecular recognition. Structure and nucleic acid binding studies of an HIV zinc finger-like domain. Biochem. Pharm. 40:1990;123-129.
252. South T. L., Blake P. R., Hare D. R., Summers M. F. C-terminal retroviral-type zinc finger domain from the HIV-1 nucleocapsid protein is structurally similar to the N-terminal zinc finger domain. Biochemistry. 30:1991;6342-6349.
253. Sova P., Volsky D. J. Efficiency of viral DNA synthesis during infection of permissive and nonpermissive cells with vif-negative human immunodeficiency virus type 1. J. Virol. 67:1993;6322-6326.
254. Sova P., Van Ranst M., Gupta P., Balachandran R., Chao W., Itescu S., McKinley G., Volsky D. J. Conservation of an intact vif gene in vitro and in vivo. J. Virol. 69:1995;2557-2564.
255. Spearman P., Wang J.-J., Vander Heyden N., Ratner L. Identification of human immunodeficiency virus type 1 gag protein domains essential to membrane binding and particle assembly. J. Virol. 68:1994;3232-3242.
256. Starcich B. R., Hahn B. H., Shaw G. M., McNeely P. D., Modrow S., Wolf H., Parks E. S., Park W. P., Josephs S. F., Gallo R. C. et al. Identification and characterization of conserved and variable regions of the envelope gene HTLV-III/LAV, the retrovirus of AIDS. Cell. 45:1986;637-648.
257. Steinkasserer A., Harrison R., Billich A., Hammerschmid F., Werner G., Wolff B., Peichl P., Palfi G., Schnitzel W., Mlynar E. et al. Mode of action of SDZ NIM 811, a nonimmunosuppressive cyclosporin A analog with activity against human immunodeficiency virus type 1 (HIV-1): interferrence with early and late events in HIV-1. J. Virol. 69:1995;814-824.
258. Stys D., Blaha I., Strop P. Structural and functional studies in vitro on the p6 protein from the HIV-1 gag open reading frame. Biochim. Biophys. Acta. 1182:1993;157-161.
259. Summers M. F. Zinc finger motif for single-stranded nucleic acids? Investigations by nuclear magnetic resonance. J. Cell. Biochem. 45:1991;41-48.
260. Summers M. F., South T. L., Kim B., Hare D. R. High-resolution structure of an HIV zinc fingerlike domain via a new NMR-based distance geometry approach. Biochemistry. 29:1990;329-340.
261. Summers M. F., Henderson L. E., Chance M. R., Bess J. W. J., South T. L., Blake P. R., Sagi I., Perez-Alvarado G., Sowder R. C. I., Hare D. R., Arthur L. O. Nucleocapsid zinc fingers detected in retroviruses: EXAFS studies of intact viruses and the solution-state structure of the nucleocapsid protein from HIV-1. Protein Sci. 1:1992;563-574.
262. 2+complex formation analysis with electrospray mass spectrometry. FEBS Letters. 311:1992;259-262.
263. Surovoy A., Dannull J., Moelling K., Jung G. Conformational and nucleic acid binding studies on the synthetic nucleocapsid protein of HIV-1. J. Mol. Biol. 229:1993;94-104.
264. Swanstrom R., Wills J. W. Synthesis, assembly and processing of viral proteins. Coffin J. M., Hughes S. H., Varmus H. E. Retroviruses. 1997;263-334 Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
265. Sweet R. W., Truneh A., Hendrickson W. A. CD4: its structure, role in immune function and AIDS pathogenesis, and potential as a pharmacological target. Curr. Opin. Biotech. 2:1991;622-633.
266. Tan K., Liu J.-H., Wang J.-H., Shen S., Lu M. Atomic structure of a thermostable subdomain of HIV-1 gp41. Proc. Nat. Acad. Sci. USA. 94:1997;12303-12308.
267. Tan R., Frankel A. D. Costabilization of peptide and RNA structure in an HIV Rev peptide-RRE complex. Biochemistry. 33:1994;14579-14585.
268. Tanchou V., Decimo D., Pechoux C., Lener D., Rogemond V., Berthoux L., Ottmann M., Darlix J.-L. Role of the N-terminal zinc finger of human immunodeficiency virus type 1 nucleocapsid protein in virus structure and replication. J. Virol. 72:1998;4442-4447.
269. Telesnitsky A., Goff S. P. Reverse transcriptase and the generation of retroviral DNA. Coffin J. M., Hughes S. H., Varmus H. E. Retroviruses. 1997;121-160 Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
270. Thali M., Moore J. P., Furman C., MacArthur C., Ho D. D., Robinson J., Sodroski J. Characterization of conserved human immunodeficiency virus type 1 gp120 neutralization epitopes exposed upon gp120-CD4 binding. J. Virol. 67:1993;3978-3988.
271. Thali M., Bukovsky A., Kondo E., Rosenwirth B., Walsh C. T., Sodroski J., Gottlinger H. G. Functional association of cyclophilin A with HIV-1 virions. Nature. 372:1994;363-365.
272. Tong L., Pav S., Pargellis C., Do F., Lamarre D., Anderson P. C. Crystal structure of human imunodeficiency virus (HIV) type 2 protease in complex with a reduced amide inhibitor and comparison with HIV-1 protease. Proc. Natl Acad. Sci. USA. 90:1993;8387-8391.
273. Trkola A., Dragic T., Arthos J., Binley J. M., Olson W. C., Allaway G. P., Cheng-Mayer C., Robinson J., Maddon P. J., Moore J. P. CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5. Nature. 384:1996;184-187.
274. Trono D. HIV accessory proteins: leading roles for the supporting cast. Cell. 82:1995;189-192.
275. Trono D., Gallay P. Letter, in response to Freed et al. Cell. 88:1997;173-174.
276. Unge T., Knight S., Bhikhabhai R., Lovgren S., Dauter Z., Wilson K., Strandberg B. 2.2 Å resolution structure of the amino-terminal half of HIV-1 reverse transcriptase (fingers and palm subdomains). Curr. Biol. 2:1994;953-961.
277. Valegard K., Liljas L., Fridborg K., Unge T. The three-dimensional structure of the bacterial virus MS2. Nature. 345:1990;36-41.
278. Vandevelde M., Witvrouw M., Schmit J.-C., Sprecher S., DeClercq E., Tassignon J. P. ADA, a potential anti-HIV drug. AIDS Res. Hum. Retrovir. 12:1996;567-568.
279. Varmus H., Swanstrom R. Replication of retroviruses. Weiss R., Teich N., Varmus H., Coffin J. Molecular Biology of Tumor Viruses. RNA Tumor Viruses. 1984;369-512 Cold Spring Harbor Laboratory Press, Cold Sprng Harbor.
280. Vodicka M. A., Koepp D. M., Silver P. A., Emerman M. HIV-1 Vpr interacts with the nuclear transport pathway to promote macrophage infection. Genes Dev. 12:1998;175-185.
281. Vogt V. M. Retroviral virions and genomes. Coffin J. M., Hughes S. H., Varmus H. E. Retroviruses. 1997;27-69 Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
282. Von Poblotzki A., Wagner R., Niedrig M., Wanner G., Wolf H., Modrow S. Identification of a region in the Pr55gag polyprotein essential for HIV-1 particle formation. Virology. 193:1993;981-985.
283. von Schwedler U., Song J., Aiken C., Trono D. Vif is crucial for human immunodeficiency virus type 1 proviral DNA synthesis in infected cells. J. Virol. 67:1993;4945-4955.
284. von Schwedler U., Kornbluth R. S., Trono D. The nuclear localization signal of the matrix protein of human immunodeficiency virus type 1 allows the establishment of infection in macrophages and quiescent t lymphocytes. Proc. Natl Acad. Sci. USA. 91:1994;6992-6996.
285. von Schwedler U. K., Stemmler T. L., Klishko V. Y., Li S., Albertine K. H., Davis D. R., Sundquist W. I. Proteolytic refolding of the HIV-1 capsid protein amino-terminus facilitates viral core assembly. EMBO J. 17:1998;1555-1568.
286. Wang C.-T., Barklis E. Assembly, processing, and infectivity of human immunodeficiency virus type 1 gag mutants. J. Virol. 67:1993;4264-4273.
287. Wang C.-T., Zhang Y., McDermott J., Barklis E. Conditional infectivity of a human immunodeficiency virus matrix domain deletion mutant. J. Virol. 67:1993;7067-7076.
288. Wang Y.-X., Freedberg D. I., Grzesiek S., Torchia D. A., Wingfield P. T., Kaufman J. D., Stahl S. J., Chang C.-H., Hodge C. N. Q. Mapping hydration water molecules in the HIV-1 protease/DMP323 complex in solution by NMR spectroscopy. Biochemistry. 35:1996;12694-12704.
289. Watenpaugh K. D., Sieker L. C., Herriott J. R., Jensen L. H. Refinement of the model of a protein: rubredoxin at 1.5 Å resolution. Acta Crystallog. sect. B. 29:1973;943-956.
290. Wei P., Garber M. E., Fang S.-M., Fischer W. H., Jones K. A. A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA. Cell. 92:1998;451-462.
291. Wei X., Ghosh S. K., Taylor M. E., Johnson V. A., Emini E. A., Deutsch P., Lifson J. D., Bonhoeffer S., Nowak M. A., Hahn B. H. et al. Viral dynamics in human immunodeficiency virus type 1 infection. Nature. 373:1995;117-122.
292. Weissenhorn W., Dessen A., Harrison S. C., Skehel J. J., Wiley D. C. Atomic structure of the ectodomain from HIV-1 gp41. Nature. 387:1997;426-430.
293. Whitcomb J. M., Hughes S. H. Retroviral reverse transcription and integration: progress and problems. Annu. Rev. Cell Biol. 8:1992;275-306.
294. Wiegers K., Rutter G., Kottler H., Tessmer U., Hohenberg H., Krausslich H.-G. Sequential steps in human immunodeficiency virus particle maturation revealed by alterations of individual Gag polyprotein cleavage sites. J. Virol. 72:1998;2846-2854.
295. Willbold D., Rosin-Arbesfeld R., Sticht H., Frank R., Rosch P. Structure of the equine infectious anemia virus Tat protein. Science. 264:1994;1584-1587.
296. src. J. Virol. 65:1991;3804-3812.
297. Wlodawer A., Erickson J. W. Structure-based inhibitors of HIV-1 proteinase. Annu. Rev. Biochem. 62:1993;543-585.
298. Wlodawer A., Miller M., Jaskolski M., Sathyanarayana B. K., Baldwin E., Weber I. T., Selk L. M., Clawson L., Schneider J., Kent B. H. S. Conserved folding in retroviral proteases: crystal structure of a synthetic HIV-1 protease. Science. 245:1989;616-621.
299. Wlodawer A., Gustchina A., Reshetnikova L., Lubkowski J., Zdanov A., Hui K. Y., Angleton E. L., Farmerie W. G., Goodenow M. M., Bhatt D., Zhang L., Dunn B. M. Structure of an inhibitor complex of the proteinase from feline immunodeficiency virus. Nature Struct. Biol. 2:1995;480-488.
300. Wong J. K., Hezareh M., Gunthard H. F., Havlir D. V., Ignacio C. C., Spina C. A., Richman D. D. Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. Science. 278:1997;1291-1295.
301. Worthylake D. K., Wang H., Yoo S., Sundquist W. I., Hill C. P. Structures of the HIV-1 capsid protein dimerization domain at 2.6 Å resolution. Acta Crystallog. sect. D. 1998.
302. Wu L., Gerard N. P., Wyatt R., Choe H., Parolin C., Ruffing N., Borsetti A., Cardoso A. A., Desjardin E., Newman W., Garard C., Sodroski J. CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR5. Nature. 384:1996;179-183.
303. Wu W., Henderson L. E., Copeland T. D., Gorelick R. J., Bosche W. J., Rein A., Levin J. G. Human immunodeficiency virus type 1 nucleocapsid protein reduces reverse transcriptase pausing at a secondary structure near the murine leukemia virus polypurine tract. J. Virol. 70:1996;7132-7142.
304. Wyatt R., Sodroski J. The HIV-1 envelope glycoproteins: fusogens, antigens and immunogens. Science. 280:1998;1884-1888.
305. Wyatt R., Moore J., Accola M., Desjardin E., Robinson J., Sodroski J. Involvement of the V1/V2 variable loop structure in the exposure of human immunodeficiency virus type 1 gp120 epitopes induced by receptor binding. J. Virol. 69:1995;5723-5733.
306. Wyatt R., Kwong P. D., Desjardins E., Sweet R. W., Robinson J., Hendrickson W. A., Sodroski J. G. The antigenic structure of the HIV gp120 envelope glycoprotein. Nature. 393:1998;705-711.
307. Yamazaki T., Hinck A. P., Wang Y.-X., Nicholson L. K., Torchia D. A., Wingfield P., Stahl S. J., Kaufman J. D., Chang C.-H., Domaille P. J., Lam P. Y. S. Three-dimensional solution structure of the HIV-1 protease complexed with DMP323, a novel cyclic urea-type inhibitor, determined by nuclear magnetic resonance spectroscopy. Protein Sci. 5:1996;495-506.
308. Ye X., Kumar R. A., Patel D. J. Molecular recognition in the bovine immunodeficiency virus tat peptide-TAR RNA complex. Chem. Biol. 2:1995;827-840.
309. Ye X., Gorin A., Ellington A. D., Patel D. J. Deep penetration of an α-helix into a widened RNA major groove in the HIV-1 rev peptide-RNA aptamer complex. Nature Struct. Biol. 3:1996;1026-1033.
310. Yoo S., Myszka D. G., Yeh C., McMurray M., Hill C. P., Sundquist W. I. Molecular recognition in the HIV-1 capsid/cyclophilin A complex. J. Mol. Biol. 269:1997;780-795.
311. Yu X., Yuan X., Matsuda Z., Lee T.-H., Essex M. The matrix protein of human immunodeficiency virus type 1 is required for incorporation of viral envelope protein into mature virions. J. Virol. 66:1992;4966-4971.
312. Yu X., Yuan X., McLane M. F., Lee T.-H., Essex M. Mutations in the cytoplasmic domain of human immunodeficiency virus type 1 transmembrane protein impair the incorporation of env proteins into mature virions. J. Virol. 67:1993;213-221.
313. Yu X., Hathout Y., Fenselau C., Sowder R. C. II, Henderson L. E., Rice W. G., Mendeleyev J., Kun E. Specific disulfide formation in the oxidation of HIV-1 zinc finger protein nucleocapsid p7. Chem. Res. Toxicol. 8:1995;586-590.
314. Yuan X., Yu X., Lee T.-H., Essex M. Mutations in the N-terminal region of human immunodeficiency virus type 1 matrix protein block intracellular transport of the gag precursor. J. Virol. 67:1993;6387-6394.
315. Zang Y., Qian H., Love Z., Barklis E. Analysis of the assembly function of the human immunodeficiency virus type 1 gag protein nucleocapsid domain. J. Virol. 72:1998;1782-1789.
316. Zapp M. L., Hope T. J., Parslow T. G., Green M. R. Oligomerization and
317. Zhang Y., Barklis E. Effects of nucleocapsid mutations on human immunodeficiency virus assembly and RNA encapsidation. J. Virol. 71:1997;6765-6776.
318. Zhao B., Winborne E., Minnich M. D., Culp J. S., Debouck C., Abdel M. S. S. Three-dimensional structure of a simian immunodeficiency virus protease/inhibitor complex. Implications for the design of human immunodeficiency virus type 1 and 2 protease inhibitors. Biochemistry. 32:1993;13054-13060.
319. Zhao R., Pevear D. C., Kremer M. J., Giranda V. L., Kofron J. A., Kuhn R. J., Rossman M. G. Human rhinovirus 3 at 3.0 Å resolution. Structure. 4:1996;1205-1220.
320. Zheng R., Jenkens T. M., Craigie R. Zinc folds the N-terminal domain of HIV-1 integrase, promotes multimerization, and enhances catalytic activity. Proc. Natl Acad. Sci. USA. 93:1996;13659-13664.
321. Zhou W., Parent L. J., Wills J. W., Resh M. D. Identification of a membrane-binding domain within the amino-terminal region of human immunodeficiency virus type 1 gag protein which interacts with acidic phospholipids. J. Virol. 68:1994;2556-2569.